Hematology - Cancer stem cells elude the body's immune cells by deactivating danger detector
Can't see this email? View it online
   
  July 23, 2019  
  Hematology  
  The latest hematology news from News Medical  
 

#ALT# Reducing Anemia in Developing Regions with Point of Care Analysis

The burden of anemia is recognized worldwide, with a global prevalence of about 25%, rising to more than 60% in some developing countries. To address this a multitude of public and NGO funded health programs are working towards achieving the ‘Second Global Nutrition Target 2025’ - a 50% reduction of anemia in women of reproductive age.

Find Out More
 
   Cancer stem cells elude the body's immune cells by deactivating danger detectorCancer stem cells elude the body's immune cells by deactivating danger detector
 
Acute myeloid leukemia stem cells elude the body's immune cells by deactivating a danger detector. The underlying mechanisms and the potential new therapeutic approaches that this gives rise to have been detailed in the journal Nature by researchers from the University of Basel and University Hospital Basel in collaboration with colleagues in Germany.
 
   Research project to investigate causes of persistent anemia among Peruvian childrenResearch project to investigate causes of persistent anemia among Peruvian children
 
The causes of persistent high levels of anemia among Peruvian children will be investigated by a new study led by Queen Mary University of London and the Instituto Nacional de Salud del Niño, in collaboration with Universidad Nacional Intercultural de la Amazonia and Universidad Nacional San Christobal de Huamanga in Peru.
 
 Study shows potential culprit behind Lupus
 
Study shows potential culprit behind LupusA new study hints at the possible origin of an autoimmune disease, Systemic Lupus Erythematosus (SLE). A team of researchers at the Emory University School of Medicine show that patients with SLE or lupus, have abnormal activation of B cells, which is part of the body’s immune system.
 
 
 Researchers identify gene mutations linked to leukemia in children with Down's syndrome
 
Researchers identify gene mutations linked to leukemia in children with Down's syndromeResearchers at the University of Oxford, in collaboration with colleagues from Hannover Medical School and Martin-Luther-University Halle-Wittenberg, have discovered the specific gene mutations that are required for the development of leukemia in children with Down's syndrome.
 
 
 Single-cell encapsulation technology can protect transplanted MSCs from immune attack
 
Single-cell encapsulation technology can protect transplanted MSCs from immune attackBone marrow transplants of hematopoietic stem cells have become standard treatment for a host of conditions including cancers of the blood and lymphatic systems, sickle cell anemia, inherited metabolic disorders, and radiation damage.
 
 
 Study: One-fifth of hematological cancer patients suffer blood clots or bleeding
 
Study: One-fifth of hematological cancer patients suffer blood clots or bleedingNew Danish research may help direct focus towards the serious complications that on average every fifth hematological cancer patient suffers. This is according to medical doctor and PhD Kasper Adelborg from Aarhus University and Aarhus University Hospital, who has studied the cases of 32,000 hematological cancer patients between the years 2000-2013. Hematological cancer includes leukemia, bone marrow cancer and cancers of the lymph nodes.
 
 
 Acute Inflammation and the Leukocyte Adhesion Cascade
 
Acute Inflammation and the Leukocyte Adhesion CascadeThe movement of leukocytes from the circulatory system to the site of inflammation and subsequent attachment forms an integral part of the innate immune system. The three steps of leukocyte rolling, activation and adhesion in response to inflammation have been well-documented and studied.